Instruments for customers in biopharma and academia
Axion at a glance
Axion Biosystems is a global life science tools business with headquarters in the US, developing, producing, and marketing BEA (Bioelectronic Assay) and live-cell imaging instruments for customers in biopharma and academia. Axion’s products enable scientists to understand cell function in real-time, enabling research and the development of new therapies across various pharmaceutical segments (e.g., cell and gene therapies).
Sector
Revenue
Location
Employees
Investment themes
The challenges we face
Healthcare systems face great challenges in terms of the quality of patient outcomes produced in the system, and waste related to ineffective treatment regimes. Healthcare systems need better tools to target disease in more effective ways and create better outcomes. The research community that is driving the development of such tools has a great need to improve its understanding of biology and understanding cell function is central to some of the most important questions related to this work. Tools for analyzing cell function is important for many pharmaceutical segments, including the development of cell and gene therapies. BEA technology provides academic and biopharma organizations the ability to deepen their understanding of cell function, enabling faster, more accurate and more cost-efficient drug discovery and development, as well as improved quality control in drug production processes.
deaths are due to Cancer globally, making it one of the leading causes of death worldwide.
average cost of getting a new drug onto the market.
How does Axion help?
Reality today
Healthcare systems need better tools to understand cell function in order to target diseases and drive patient outcomes.
Axion Approach
Axion enables multi-dimensional, interoperable live-cell analysis to improve drug discovery and development, drive breakthroughs in cell and gene therapies, and ultimately enable superior health outcomes.
Aspirational future
Faster, more accurate and more cost-efficient drug discovery and development for precision medicine.
Who is impacted?
Researchers and biopharma are impacted directly through more effective tools to understand cell function. Patients are impacted indirectly through breakthroughs in treatment developments.
What are the impact considerations?
Additionality
Without Axion, academia and biopharma would have less insight into cell function, slowing down the time and reducing the quality of critical drug development.
Risks
Axion’s impact depends in part on how its customers in academia and biopharma choose to use its tools. Axion can engage customers to help ensure that the research and innovation it enables translates into patient outcomes downstream.
SDG alignments
